Ranjbar Reza, Nazari Sedigheh, Farahani Omid
Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Department of Microbiology, Damghan Branch, Islamic Azad University, Damghan, Iran.
Iran J Public Health. 2020 Sep;49(9):1743-1749. doi: 10.18502/ijph.v49i9.4094.
as one of the most predominant pathogens is the major cause of urinary tract infections (UTI) worldwide. strains could be classified into distinct phylo-groups based on PCR method. Additionally, studying the antimicrobial resistance profiles of these strains is essential for finding the effective selection of treatment and evaluating the differences among resistance patterns of particular phylogenetic groups. This study aimed to determine the phylogroups of isolated from patients with UTI in Tehran, Iran.
The urine samples were collected from patients suspected to UTI from four hospitals in Tehran, Iran; Mofid, Vali-Asr, Bu-Ali and Tehran Heart Center (THC) Hospitals during 2014-2016. Assessing the antimicrobial resistance profile of the identified strains was accomplished using ampicillin, ceftriaxone, cefotaxime, and ceftazidime among β-lactam group; gentamicin, and streptomycin among aminoglycosides; nalidixic acid and norfloxacin from quinolones; and chloramphenicol disks. The phylogenetic characterization of 60 E. coli isolates obtained from patients with UTI was done by triplex PCR method.
strains showed high resistance toward streptomycin (93.33%), ampicillin (86.6%) and nalidixic acid (73.33%) while resistance against chloramphenicol showed the lowest (10%). The prevalent groups were B2 (n=50/60, 83%), followed by D (n=6/60, 10%), B1 (n=3/60, 5%), and A (n=1, 1.6%).
The most predominant phylogenetic group was B2 with the major frequent detected with the major drug resistant (48%) compared to other Phylogenetic groups.
作为最主要的病原体之一,是全球范围内尿路感染(UTI)的主要病因。基于PCR方法,菌株可被分为不同的系统发育群。此外,研究这些菌株的抗菌药物耐药谱对于找到有效的治疗选择以及评估特定系统发育群耐药模式之间的差异至关重要。本研究旨在确定从伊朗德黑兰尿路感染患者中分离出的的系统发育群。
尿液样本于2014 - 2016年期间从伊朗德黑兰的四家医院(莫菲德医院、瓦利 - 阿斯尔医院、布阿里医院和德黑兰心脏中心(THC)医院)疑似患有UTI的患者中采集。使用β - 内酰胺类中的氨苄西林、头孢曲松、头孢噻肟和头孢他啶;氨基糖苷类中的庆大霉素和链霉素;喹诺酮类中的萘啶酸和诺氟沙星;以及氯霉素纸片来评估鉴定出的菌株的抗菌药物耐药谱。通过三重PCR方法对从UTI患者中获得的60株大肠杆菌分离株进行系统发育特征分析。
菌株对链霉素(93.33%)、氨苄西林(86.6%)和萘啶酸(73.33%)表现出高耐药性,而对氯霉素的耐药性最低(10%)。流行的群体是B2(n = 50/60,83%),其次是D(n = 6/60,10%),B1(n = 3/60,5%)和A(n = 1,1.6%)。
最主要的系统发育群是B2,与其他系统发育群相比,主要频繁检测到主要耐药(48%)。